GleamWall
中文EN

CVS CVS HEALTH Corp

Retail-Drug Stores and Proprietary Stores · NYSE · SEC CIK 64803 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.7%
TTM net income YoY2,253.3%
TTM EPS YoY2,165.8%
Revenue 3-yr CAGR6.5%
Net income 3-yr CAGR8.5%

Margins

Gross margin44.2%
Operating margin3.6%
Net margin2.6%
FCF margin3.7%
EBITDA margin4.7%

Returns

ROE14.4%
ROA4.3%
ROIC (approx.)10.8%
Asset turnover1.64x

Leverage & solvency

Liabilities / assets68.7%
Debt / equity0.75x
Current ratio0.85x
Interest coverage4.91x

Cash quality & payout

Operating cash flow / net income1.70x
Accruals ratio-3.0%
Payout ratio31.0%
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$402.07B$372.81B
Cost of revenue$221.17B$206.29B
Gross profit$180.90B$166.52B
Operating income$4.66B$8.52B
Interest expense$3.12B$2.96B
Pretax income$2.14B$6.15B
Income tax$408.00M$1.56B
Net income$1.77B$4.61B
EBITDA$9.27B$13.11B
EPS (basic)1.403.67
EPS (diluted)1.393.66
Dividends declared per share2.662.66
Weighted avg. shares (diluted)1.27B1.26B
Balance sheet
Cash & equivalents$8.45B$8.88B
Short-term investments$2.15B$2.41B
Receivables$39.78B$36.47B
Inventory$19.25B$18.11B
Current assets$74.71B$68.64B
PP&E, net$13.08B$12.99B
Goodwill$85.48B$91.27B
Intangibles$25.51B$27.32B
Total assets$253.54B$253.22B
Current liabilities$88.69B$84.61B
Short-term debt$4.07B$2.12B
Long-term debt$60.50B$60.53B
Total debt$64.57B$62.65B
Total liabilities$178.16B$177.49B
Shareholders' equity$75.21B$75.56B
Net debt$56.12B$53.76B
Shares outstanding1.27B1.26B
Cash flow statement
Operating cash flow$10.64B$9.11B
Capital expenditure$2.83B$2.78B
Free cash flow$7.81B$6.33B
Investing cash flow-$5.87B-$7.61B
Financing cash flow-$4.94B-$1.14B
Depreciation & amortization$4.61B$4.60B
Stock-based compensation$535.00M$540.00M
Dividends paid$3.40B$3.37B
Share buybacks$0$3.02B

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.